Association between the functional variant of the catechol-O-methyltransferase (COMT) gene and type 1 alcoholism.
paper
Cited
Public
Unavailable
- Authors
- Tiihonen, J; Hallikainen, T; Lachman, H; Saito, T; Volavka, J; Kauhanen, J; Salonen, J T; Ryynänen, O P; Koulu, M; Karvonen, M K; Pohjalainen, T; Syvälahti, E; Hietala, J
- Year
- 1999
- Journal
- Molecular psychiatry
- PMID
- 10395222
- DOI
- 10.1038/sj.mp.4000509
Catechol-O-methyltransferase (COMT) is an enzyme which has a crucial role in the metabolism of dopamine. It has been suggested that a common functional genetic polymorphism in the COMT gene, which results in 3 to 4-fold difference in COMT enzyme activity, may contribute to the etiology of mental disorders such as bipolar disorder and alcoholism. Since ethanol-induced euphoria is associated with the rapid release of dopamine in limbic areas, it is conceivable that subjects who inherit the allele encoding the low activity COMT variant would have a relatively low dopamine inactivation rate, and therefore would be more vulnerable to the development of ethanol dependence. The aim of this study was to test this hypothesis among type 1 (late-onset) alcoholics. The COMT polymorphism was determined in two independent male late onset (type 1) alcoholic populations in Turku (n = 67) and Kuopio (n = 56). The high (H) and low (L) activity COMT genotype and allele frequencies were compared with previously published data from 3140 Finnish blood donors (general population) and 267 race- and gender-matched controls. The frequency of low activity allele (L) was markedly higher among the patients both in Turku (P = 0.023) and in Kuopio (P = 0.005) when compared with the general population. When all patients were compared with the general population (blood donors), the difference was even more significant (P = 0.0004). When genotypes of all alcoholics (n = 123) were compared with genotypes of matched controls, the odds ratio (OR) for alcoholism for those subjects having the LL genotype vs those with HH genotype was 2.51, 95% CI 1.22-5.19, P = 0.006. Also, L allele frequency was significantly higher among alcoholics when compared with controls (P = 0.009). The estimate for population etiological (attributable) fraction for the LL genotype in alcoholism was 13.3% (95% CI 2.3-25.7%). The results indicate that the COMT polymorphism contributes significantly to the development of late-onset alcoholism.
No figures extracted from this document.
No chunks — full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Genetic determinants of longitudinal behavioural trajectories in rare conditions: The case of fragile X syndrome. | Cartwright L et al. | — | 2025 | → |
| To Each His Own Fear: Gender-Related Association of Anxiety, Substance Use, and Eating Disorders in a Representative Birth Cohort Sample of Young Adults with Either COMT Val158Met allele. | Kiive E et al. | — | 2024 | → |
| ADHD co-morbidities: A review of implication of gene × environment effects with dopamine-related genes. | Kanarik M et al. | — | 2022 | → |
| Alcohol Use Disorder: Neurobiology and Therapeutics. | Yang W et al. | — | 2022 | → |
| Associations between the <i>COMT</i> rs4680 Gene Polymorphism and Personality Dimensions and Anxiety in Patients with a Diagnosis of Other Stimulants Dependence. | Chmielowiec K et al. | — | 2022 | → |
| FACTORS CONTRIBUTING TO THE ESCALATION OF ALCOHOL CONSUMPTION. | Bowen MT et al. | — | 2022 | → |
| Catechol-O-methyltransferase (COMT) Val158Met Polymorphism and Susceptibility to Alcohol Dependence. | Chaudhary A et al. | — | 2021 | → |
| Dimensions of Craving Interact with <i>COMT</i> Genotype to Predict Relapse in Individuals with Alcohol Use Disorder Six Months after Treatment. | Padula CB et al. | — | 2021 | → |
| Influence of dopamine-related genes on craving, impulsivity, and aggressiveness in Korean males with alcohol use disorder. | Park CI et al. | — | 2021 | → |
| Spontaneous Ultrasonic Vocalization Transmission in Adult, Male Long-Evans Rats Is Age-Dependent and Sensitive to EtOH Modulation. | Mittal N et al. | — | 2020 | → |
| Differential COMT expression and behavioral effects of COMT inhibition in male and female Wistar and alcohol preferring rats. | McCane AM et al. | — | 2018 | → |
| Early Life Stress as a Predictor of Co-Occurring Alcohol Use Disorder and Post-Traumatic Stress Disorder. | Lee RS et al. | — | 2018 | → |
| Genetic Association and Expression Analyses of the Phosphatidylinositol-4-Phosphate 5-Kinase (PIP5K1C) Gene in Alcohol Use Disorder-Relevance for Pain Signaling and Alcohol Use. | Lee JS et al. | — | 2018 | → |
| Comorbidity of Alcohol Use Disorder and Chronic Pain: Genetic Influences on Brain Reward and Stress Systems. | Yeung EW et al. | — | 2017 | → |
| Environmental risks outweigh dopaminergic genetic risks for alcohol use and abuse from adolescence through early adulthood. | Coley RL et al. | — | 2017 | → |
| Genetic studies of alcohol dependence in the context of the addiction cycle. | Reilly MT et al. | — | 2017 | → |
| Is there a genetic support for the Cloninger (type I/II) clinical classification of alcohol addiction? | Pombo S et al. | — | 2017 | → |
| Candidate genes for alcohol dependence: A genetic association study from India. | Malhotra S et al. | — | 2016 | → |
| High Resolution Genomic Scans Reveal Genetic Architecture Controlling Alcohol Preference in Bidirectionally Selected Rat Model. | Lo CL et al. | — | 2016 | → |
| Influence of Dopaminergic System Genetic Variation and Lifestyle Factors on Excessive Alcohol Consumption. | Celorrio D et al. | — | 2016 | → |
| Association between catechol-O-methyltransferase (COMT) Val/Met genotype and smoking cessation treatment with nicotine: a meta-analysis. | Choi HD et al. | — | 2015 | → |
| Association between the catechol-O-methyltransferase polymorphism Val158Met and Alzheimer's disease in a Japanese population. | Shibata N et al. | — | 2015 | → |
| Biopsychosocial influence on shoulder pain: risk subgroups translated across preclinical and clinical prospective cohorts. | George SZ et al. | — | 2015 | → |
| Common single nucleotide variants underlying drug addiction: more than a decade of research. | Bühler KM et al. | — | 2015 | → |
| COMT and MAO-A polymorphisms and obsessive-compulsive disorder: a family-based association study. | Sampaio AS et al. | — | 2015 | → |
| COMT Associations with Disordered Gambling and Drinking Measures. | Guillot CR et al. | — | 2015 | → |
| Multidimensional alcoholism typologies: could they guide clinical practice? Results from a 3-month prospective study. | Pombo S et al. | — | 2015 | → |
| Comprehensive interrogation of CpG island methylation in the gene encoding COMT, a key estrogen and catecholamine regulator. | Swift-Scanlan T et al. | — | 2014 | → |
| Replica exchange Monte Carlo simulation of human serum albumin-catechin complexes. | Li Y et al. | — | 2014 | → |
| COMT Val158Met modulates the effect of childhood adverse experiences on the risk of alcohol dependence. | Schellekens AF et al. | — | 2013 | → |
| Peter Riederer "70th birthday" neurobiological foundations of modern addiction treatment. | Jacob C | — | 2013 | → |
| Alcohol dependence as a chronic pain disorder. | Egli M et al. | — | 2012 | → |
| Catechol-O-methyltransferase Val158 Met genotype, parenting practices and adolescent alcohol use: testing the differential susceptibility hypothesis. | Laucht M et al. | — | 2012 | → |
| COMT and ALDH2 polymorphisms moderate associations of implicit drinking motives with alcohol use. | Hendershot CS et al. | — | 2012 | → |
| Convergence of genome-wide association and candidate gene studies for alcoholism. | Olfson E et al. | — | 2012 | → |
| Effects of COMT polymorphisms on brain function and behavior in health and disease. | Witte AV et al. | — | 2012 | → |
| Genetic variations in the dopaminergic system and alcohol use: a system-level analysis. | Chen C et al. | — | 2012 | → |
| The genetic basis of addictive disorders. | Ducci F et al. | — | 2012 | → |
| The relationship between risk-taking propensity and the COMT Val(158)Met polymorphism among early adolescents as a function of sex. | Amstadter AB et al. | — | 2012 | → |
| A COMT gene haplotype associated with methamphetamine abuse. | Jugurnauth SK et al. | — | 2011 | → |
| A novel SNP in COMT is associated with alcohol dependence but not opiate or nicotine dependence: a case control study. | Voisey J et al. | — | 2011 | → |
| Association study of a functional catechol-O-methyltransferase (COMT) Val108/158Met polymorphism and suicide attempts in patients with alcohol dependence. | Nedic G et al. | — | 2011 | → |
| COMT moderates the relation of daily maladaptive coping and pain in fibromyalgia. | Finan PH et al. | — | 2011 | → |
| Effect of COMT genotype on aggressive behaviour in a community cohort of schizophrenic patients. | Tosato S et al. | — | 2011 | → |
| Genetics of alcohol dependence. | Kimura M et al. | — | 2011 | → |
| P2RX7 gene is associated consistently with mood disorders and predicts clinical outcome in three clinical cohorts. | Soronen P et al. | — | 2011 | → |
| Personality Measurement and Assessment in Large Panel Surveys* | Roberts B et al. | — | 2011 | → |
| Are genetic variants of COMT associated with addiction? | Tammimäki AE et al. | — | 2010 | → |
| Differential effects of COMT on gait and executive control in aging. | Holtzer R et al. | — | 2010 | → |
| Genetic influences on the dynamics of pain and affect in fibromyalgia. | Finan PH et al. | — | 2010 | → |
| Neural markers of genetic vulnerability to drug addiction. | Müller DJ et al. | — | 2010 | → |
| Pharmacogenetics of drug dependence: role of gene variations in susceptibility and treatment. | Khokhar JY et al. | — | 2010 | → |
| Phase II drug metabolizing enzymes. | Jancova P et al. | — | 2010 | → |
| Genetic and non-genetic influences on the development of co-occurring alcohol problem use and internalizing symptomatology in adolescence: a review. | Saraceno L et al. | — | 2009 | → |
| Identification of a novel haplotype of the human catechol-O-methyltransferase gene. | Bai HW et al. | — | 2009 | → |
| Impulsivity, frontal lobes and risk for addiction. | Crews FT et al. | — | 2009 | → |
| Phosphorylated and non-phosphorylated forms of catechol O-methyltransferase in rat liver, brain and other tissues. | Øverbye A et al. | — | 2009 | → |
| The genetic basis of individual differences in reward processing and the link to addictive behavior and social cognition. | Yacubian J et al. | — | 2009 | → |
| The genetics of deliria. | Adamis D et al. | — | 2009 | → |
| A community-based study of cigarette smoking behavior in relation to variation in three genes involved in dopamine metabolism: Catechol-O-methyltransferase (COMT), dopamine beta-hydroxylase (DBH) and monoamine oxidase-A (MAO-A). | Shiels MS et al. | — | 2008 | → |
| Approach to the genetics of alcoholism: a review based on pathophysiology. | Köhnke MD | — | 2008 | → |
| Association between the catechol-O-methyltransferase Val158Met polymorphism and cocaine dependence. | Lohoff FW et al. | — | 2008 | → |
| Catechol-O-methyltransferase (COMT) gene variants: possible association of the Val158Met variant with opiate addiction in Hispanic women. | Oosterhuis BE et al. | — | 2008 | → |
| Genetic approaches to addiction: genes and alcohol. | Ducci F et al. | — | 2008 | → |
| Genetics and neuroimaging of attention and hypnotizability may elucidate placebo. | Raz A | — | 2008 | → |
| Genetics of Lesch's typology of alcoholism. | Samochowiec J et al. | — | 2008 | → |
| Increase in free choice oral ethanol self-administration in catechol-o-methyltransferase gene-disrupted male mice. | Tammimäki A et al. | — | 2008 | → |
| The catechol-O-methyl transferase Val158Met polymorphism and susceptibility to cannabis dependence. | Baransel Isir AB et al. | — | 2008 | → |
| The V108M mutation decreases the structural stability of catechol O-methyltransferase. | Rutherford K et al. | — | 2008 | → |
| Experimentally induced aggressiveness in heroin-dependent patients treated with buprenorphine: comparison of patients receiving methadone and healthy subjects. | Gerra G et al. | — | 2007 | → |
| Functional COMT Val158Met polymorphism, risk of acute coronary events and serum homocysteine: the Kuopio ischaemic heart disease risk factor study. | Voutilainen S et al. | — | 2007 | → |
| Genetic and environmental factors in complex neurodevelopmental disorders. | van Loo KM et al. | — | 2007 | → |
| Genetic Contribution of Catechol-O-methyltransferase Polymorphism in Patients with Migraine without Aura. | Park JW et al. | — | 2007 | → |
| Genetic variation in catechol-O-methyltransferase (COMT) and obesity in the prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial. | Wang SS et al. | — | 2007 | → |
| Immediate reward bias in humans: fronto-parietal networks and a role for the catechol-O-methyltransferase 158(Val/Val) genotype. | Boettiger CA et al. | — | 2007 | → |
| Lack of association of alcohol dependence and habitual smoking with catechol-O-methyltransferase. | Foroud T et al. | — | 2007 | → |
| Manipulation of catechol-O-methyl-transferase (COMT) activity to influence the attenuation of substance seeking behavior, a subtype of Reward Deficiency Syndrome (RDS), is dependent upon gene polymorphisms: a hypothesis. | Blum K et al. | — | 2007 | → |
| Role of the COMT gene Val158Met polymorphism in mental disorders: a review. | Hosák L | — | 2007 | → |
| An overview of the genetics of substance use disorders. | Lachman HM | — | 2006 | → |
| Direct molecular haplotyping of multiple polymorphisms within exon 4 of the human catechol-O-methyltransferase gene by liquid chromatography-electrospray ionization time-of-flight mass spectrometry. | Oberacher H et al. | — | 2006 | → |
| Genetic and environmental influences on the development of alcoholism: resilience vs. risk. | Enoch MA | — | 2006 | → |
| Sex differences in the influence of COMT Val158Met on alcoholism and smoking in plains American Indians. | Enoch MA et al. | — | 2006 | → |
| Significant association of catechol-O-methyltransferase (COMT) haplotypes with nicotine dependence in male and female smokers of two ethnic populations. | Beuten J et al. | — | 2006 | → |
| The effects of catechol O-methyltransferase genotype on brain activation elicited by affective stimuli and cognitive tasks. | Heinz A et al. | — | 2006 | → |
| Association between the COMT Val158Met polymorphism and propensity to anxiety in an Australian population-based longitudinal study of adolescent health. | Olsson CA et al. | — | 2005 | → |
| Association study of catechol-O-methyltransferase gene polymorphism in Korean male alcoholics. | Kweon YS et al. | — | 2005 | → |
| Catechol-O-methyltransferase val158met genotype affects processing of emotional stimuli in the amygdala and prefrontal cortex. | Smolka MN et al. | — | 2005 | → |
| Functional and structural comparisons of cysteine residues in the Val108 wild type and Met108 variant of human soluble catechol O-methyltransferase. | Li Y et al. | — | 2005 | → |
| Functional imaging research in schizophrenia. | Tost H et al. | — | 2005 | → |
| Future contributions on genetics. | Krebs MO | — | 2005 | → |
| [One decade of functional imaging in schizophrenia research. From visualisation of basic information processing steps to molecular-genetic oriented imaging]. | Tost H et al. | — | 2005 | → |
| The genetics of addictions: uncovering the genes. | Goldman D et al. | — | 2005 | → |
| Aggressive responding in abstinent heroin addicts: neuroendocrine and personality correlates. | Gerra G et al. | — | 2004 | → |
| Association analysis of the DRD4 and COMT genes in methamphetamine abuse. | Li T et al. | — | 2004 | → |
| Catechol-O-methyltransferase polymorphism alters hypothalamic-pituitary-adrenal axis responses to naloxone: a preliminary report. | Oswald LM et al. | — | 2004 | → |
| Genes associated with addiction: alcoholism, opiate, and cocaine addiction. | Kreek MJ et al. | — | 2004 | → |
| Oxidative inhibition of human soluble catechol-O-methyltransferase. | Cotton NJ et al. | — | 2004 | → |
| Pharmacogenetic insights to monoaminergic dysfunction in alcohol dependence. | Heinz A et al. | — | 2004 | → |
| The catechol-O-methyltransferase polymorphism: relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes. | Bilder RM et al. | — | 2004 | → |
| Association analysis of MAOA and COMT with neuroticism assessed by peers. | Eley TC et al. | — | 2003 | → |
| COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor. | Zubieta JK et al. | — | 2003 | → |
| Ethanol consumption and DRD2 gene TaqI a polymorphism among socially drinking males. | Hallikainen T et al. | — | 2003 | → |
| Genetically mediated brain abnormalities in schizophrenia. | Seidman LJ et al. | — | 2003 | → |
| Genetic origins of anxiety in women: a role for a functional catechol-O-methyltransferase polymorphism. | Enoch MA et al. | — | 2003 | → |
| Normal genetic variation, cognition, and aging. | Greenwood PM et al. | — | 2003 | → |
| Pain thresholds in alcohol preferring and non-preferring rats: diurnal and repeated trial line differences. | Kimpel MW et al. | — | 2003 | → |
| Pharmacogenomics of alcohol response and addiction. | Enoch MA | — | 2003 | → |
| Plasma homovanillic acid: a significant association with alcoholism is independent of a functional polymorphism of the human catechol-O-methyltransferase gene. | Köhnke MD et al. | — | 2003 | → |
| Relationship between catechol-O-methyltransferase polymorphism and treatment-resistant schizophrenia. | Inada T et al. | — | 2003 | → |
| Thoughts on individualizing hormone replacement therapy based on the postmenopausal health disparities study data. | Gavaler JS | — | 2003 | → |
| Toward a molecular architecture of personality. | Reif A et al. | — | 2003 | → |
| Transgenic mouse models of dopamine deficiency. | Chen L et al. | — | 2003 | → |
| Analysis of monoamine oxidase A (MAOA) promoter polymorphism in Finnish male alcoholics. | Saito T et al. | — | 2002 | → |
| No association between functional catechol O-methyl transferase 1947A>G polymorphism and smoking initiation, persistent smoking or smoking cessation. | David SP et al. | — | 2002 | → |
| Separation methods for catechol O-methyltransferase activity assay: physiological and pathophysiological relevance. | Pihlavisto P et al. | — | 2002 | → |
| Aggressive responding of male heroin addicts under methadone treatment: psychometric and neuroendocrine correlates. | Gerra G et al. | — | 2001 | → |
| Association study of the low-activity allele of catechol-O-methyltransferase and alcoholism using a family-based approach. | Wang T et al. | — | 2001 | → |
| The additive effect of neurotransmitter genes in pathological gambling. | Comings DE et al. | — | 2001 | → |
| The genetics of alcoholism and alcohol abuse. | Enoch MA et al. | — | 2001 | → |
| Association between polymorphisms in dopamine metabolic enzymes and tobacco consumption in smokers. | McKinney EF et al. | — | 2000 | → |
| Association between the functional polymorphism of catechol-O-methyltransferase gene and alcohol consumption among social drinkers. | Kauhanen J et al. | — | 2000 | → |
| Dietary intake and bioavailability of polyphenols. | Scalbert A et al. | — | 2000 | → |
| Lack of association between the functional variant of the catechol-o-methyltransferase (COMT) gene and early-onset alcoholism associated with severe antisocial behavior. | Hallikainen T et al. | — | 2000 | → |
| Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. | Männistö PT et al. | — | 1999 | → |